Double Medical Technology Inc. Stock
Equities
002901
CNE1000032W7
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.40 CNY | -0.43% | -1.64% | -20.18% |
Capitalization | 13.27B 1.83B 1.74B 1.61B 1.44B 2.59B 155B 2.87B 20.1B 7.42B 63.76B 6.87B 6.72B 278B | P/E ratio 2024 * |
44x | P/E ratio 2025 * | 28.9x |
---|---|---|---|---|---|
Enterprise value | 13.27B 1.83B 1.74B 1.61B 1.44B 2.59B 155B 2.87B 20.1B 7.42B 63.76B 6.87B 6.72B 278B | EV / Sales 2024 * |
6.58x | EV / Sales 2025 * | 5.15x |
Free-Float |
13.68% | Yield 2024 * |
-
| Yield 2025 * | - |
1 day | +0.18% | ||
1 week | -1.21% | ||
Current month | -0.70% | ||
1 month | -6.41% | ||
3 months | +35.64% | ||
6 months | +16.59% | ||
Current year | -19.83% |
Director | Title | Age | Since |
---|---|---|---|
Jiong Luo
CEO | Chief Executive Officer | 56 | 2011-05-31 |
Dan He Chen
DFI | Director of Finance/CFO | 44 | 2023-08-29 |
Shao Jian Han
CTO | Chief Tech/Sci/R&D Officer | 44 | 2015-11-22 |
Manager | Title | Age | Since |
---|---|---|---|
Zhi Xiong Lin
CHM | Chairman | 51 | 2004-07-31 |
Zhi Jun Lin
BRD | Director/Board Member | 49 | 2008-04-30 |
Jiong Luo
BRD | Director/Board Member | 56 | 2017-04-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 92 M€ | +15.66% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.18% | -1.21% | -17.70% | -32.85% | 1.83B | ||
+0.41% | -2.12% | +32.37% | +47.07% | 146B | ||
+0.08% | -0.28% | -5.35% | -19.38% | 11.03B | ||
+3.82% | +1.47% | +7.84% | -50.11% | 8.99B | ||
-1.67% | +0.28% | +114.33% | +230.30% | 7.52B | ||
-0.05% | -1.29% | +14.74% | -13.90% | 5.68B | ||
+0.75% | -.--% | +24.92% | +33.35% | 3.63B | ||
-1.83% | -5.04% | -6.00% | -65.84% | 2.6B | ||
+0.11% | +1.60% | -9.03% | -36.82% | 2.28B | ||
+1.52% | +7.90% | -15.29% | -33.49% | 1.88B | ||
Average | +0.33% | +0.86% | +14.08% | +5.83% | 19.13B | |
Weighted average by Cap. | +0.44% | -1.40% | +29.63% | +39.71% |
2024 * | 2025 * | |
---|---|---|
Net sales | 2.02B 278M 265M 245M 218M 394M 23.59B 436M 3.05B 1.13B 9.69B 1.04B 1.02B 42.28B | 2.58B 356M 338M 314M 279M 504M 30.18B 558M 3.91B 1.44B 12.39B 1.33B 1.31B 54.07B |
Net income | 305M 42.05M 40.03M 37.09M 32.99M 59.56M 3.57B 66M 462M 171M 1.47B 158M 154M 6.39B | 466M 64.25M 61.15M 56.67M 50.41M 90.99M 5.45B 101M 706M 261M 2.24B 241M 236M 9.77B |
Net Debt | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-12-10 | 32.40 ¥ | -0.43% | 1,060,000 |
24-12-10 | 32.54 ¥ | +0.18% | 1,157,800 |
24-12-09 | 32.48 ¥ | -1.10% | 1,215,800 |
24-12-06 | 32.84 ¥ | +1.20% | 907,606 |
24-12-05 | 32.45 ¥ | +0.81% | 542,200 |
End-of-day quote Shenzhen S.E., December 09, 2024
More quotesAnnual profits - Rate of surprise
- Stock Market
- Equities
- 002901 Stock